BUSINESS● LOW4d ago · Oct 29, 2026, 10:31 AM
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
CNBC · north america
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS17m agoChina moves to simplify forex settlements and make cross-border business easierSouth China Morning PostBUSINESS23m agoMaharashtra FDA confiscates Patanjali stock, suspends licencesThe Hindu